Docket
117th Congress · HOUSE BILLBILL

H.R. 597 — Pandemic Treatment Access and Affordability Act of 2021

“To require any COVID-19 drug developed in whole or in part with Federal support to be affordable and accessible by prohibiting monopolies and price gouging, and for other purposes.”

Health
Introduced Jan 28, 2021
Last action Mar 22, 2021
Pipeline · Bill → Law
Step 1
Introduced
Jan 28, 2021
Step 2
Referred
Mar 22, 2021
Armed Services · E&C · Judiciary +1
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryNo summary available

No CRS summary available for this bill.

Provisions · 5 sectionsIntroduced in House
Timeline · 7 actions
Mar 22, 2021
Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Feb 2, 2021
Referred to the Subcommittee on Health.
Jan 28, 2021
Introduced in House
Jan 28, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Science, Space, and Technology, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 28, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Science, Space, and Technology, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 28, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Science, Space, and Technology, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 28, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Science, Space, and Technology, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.